Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma

BACKGROUND: Modified response evaluation criteria in solid tumors (mRECIST) and RECIST are used to assess the effect of treatment with targeted agents for hepatocellular carcinoma (HCC). The aim of this study was to determine which set of criteria is superior in patients with advanced HCC treated wi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Res Notes
Main Authors: Takada, Juichi, Hidaka, Hisashi, Nakazawa, Takahide, Kondo, Masaaki, Numata, Kazushi, Tanaka, Katsuaki, Matsunaga, Kotaro, Okuse, Chiaki, Kobayashi, Satoshi, Morimoto, Manabu, Ohkawa, Shinichi, Koizumi, Wasaburo
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4624170/
https://ncbi.nlm.nih.gov/pubmed/26502722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1565-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares